HR Healthcare Realty Trust Inc
Real Estate Investment Trusts · NYSE · SEC CIK 1360604 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.8%
TTM net income YoY87.8%
TTM EPS YoY86.9%
Revenue 3-yr CAGR-5.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-4.0%
FCF margin—
EBITDA margin—
Returns
ROE-1.0%
ROA-0.5%
ROIC (approx.)—
Asset turnover0.12x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity1.04x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-10.01x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.18B | $1.27B | $1.34B | $932.64M | $534.82M |
| SG&A expense | $72.57M | $83.12M | $58.41M | $52.73M | $34.15M |
| Interest expense | $208.99M | $242.43M | $258.58M | $146.69M | $53.12M |
| Net income | -$246.07M | -$654.49M | -$278.26M | $40.90M | $66.66M |
| EPS (basic) | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 |
| EPS (diluted) | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 |
| Dividends declared per share | 1.10 | 1.24 | 1.24 | 1.24 | 1.21 |
| Weighted avg. shares (diluted) | 349.80M | 365.55M | 378.93M | 253.87M | 142.71M |
| Banking | |||||
| Loans, net | $123.25M | $123.67M | $122.60M | $120.24M | — |
| Balance sheet | |||||
| Cash & equivalents | $26.17M | $68.92M | $25.70M | $60.96M | $13.18M |
| Goodwill | — | $0 | $250.53M | $223.20M | $3.49M |
| Intangibles | — | — | — | — | $212.45M |
| Total assets | $9.21B | $10.65B | $12.64B | $13.85B | $4.26B |
| Long-term debt | $3.91B | $4.66B | $4.99B | $5.35B | $1.80B |
| Total debt | $3.91B | $4.66B | $4.99B | $5.35B | $1.80B |
| Total liabilities | $4.53B | $5.35B | $5.71B | $6.17B | $2.07B |
| Shareholders' equity | $4.62B | $5.23B | $6.82B | $7.57B | $2.19B |
| Net debt | $3.89B | $4.59B | $4.97B | $5.29B | $1.79B |
| Shares outstanding | 351.60M | 350.53M | 380.96M | 380.59M | 150.46M |
| Cash flow statement | |||||
| Operating cash flow | $457.10M | $501.62M | $499.82M | $272.75M | $232.63M |
| Capital expenditure | — | — | — | — | $97.16M |
| Free cash flow | — | — | — | — | $135.47M |
| Investing cash flow | $710.83M | $900.92M | $349.14M | $1.63B | -$562.47M |
| Financing cash flow | -$1.21B | -$1.36B | -$884.22M | -$1.86B | $327.72M |
| Depreciation & amortization | $563.97M | $675.15M | $730.71M | $453.08M | $202.71M |
| Stock-based compensation | $22.39M | $31.82M | $14.29M | $20.35M | $10.73M |
| Dividends paid | $386.92M | $457.85M | $472.24M | $283.71M | $175.46M |
| Share buybacks | $4.01M | $8.88M | $2.30M | $3.19M | $3.80M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.